Evolution Icon Evolution
Intelligent Design Icon Intelligent Design
Medicine Icon Medicine

No, Despite Often-Heard Claims, Antibiotic Resistance in Bacteria Is Not Evolution

1280px-Antibiotic_sensitvity_and_resistance.JPG

Darwinian biologist and blogger P.Z. Myers wrote a post recently in which he lamented the fact that medical researchers rarely invoke evolution in their published research, whereas evolutionary biologists routinely invoke evolution. This is of course true.

I pointed out that this is because evolutionary inferences are of no significant help to medical research. Inference to evolution is a narrative gloss on the real science in medicine. It is a point that I, along with others, have been making for years. Myers unintentionally provides striking confirmation that doctors and medical researchers don’t refer to evolution because it’s irrelevant to their science.

Now Myers writes a follow-up post in which he insists that evolution is relevant to medicine, despite the virtual absence of evolutionary reasoning expressed in the medical literature. Specifically, he insists that bacterial resistance to antibiotics is an example of evolution — a common claim — and he scolds doctors and medical scientists for not explicitly saying so in their research.

You hear this all the time in the media. Writing in The New Yorker last week, for example, Adam Gopnik scolded evolution doubters:

Evolutionary science is not abstract — evaluating reports of a “superbug” in Los Angeles, wrought immune by natural selection to antibiotics, means applying Darwinian principles as they go about their often scary work.

This notion, however, is mistaken. Bacterial resistance to antibiotics has nothing to do with evolution. Evolution, in the Darwinian sense of undirected (unintelligent) process of random heritable variation and natural selection, is the process by which populations of living things change over time without intelligent agency causing or guiding the process. When the process of change in populations is guided by intelligence, it is called artificial selection — breeding.

Of course I’m not the first to point this out. Charles Darwin, in the Origin of Species, made exactly the same argument. In his first chapter, he discussed artificial selection — animal husbandry and breeding of plants. In subsequent chapters he developed an argument that in nature, changes in population are accomplished by natural selection, without intelligent agency. Darwin distinguished artificial selection from natural selection — he distinguished breeding from evolution, and of course his theory of evolution is a theory of natural selection, not a theory of animal husbandry or plant breeding, which had been practiced for thousands of years and to which Darwin contributed nothing.

Bacterial resistance to antibiotics is artificial selection. Antibiotics are intelligently designed by medical researchers, deliberately administered to patients by doctors, who understand that there are some bacteria that are not sensitive to the antibiotic and that have the potential to proliferate. Actually, the administration of antibiotics that kill some but not all of the bacteria in the patient is quite deliberate, because there are huge populations of beneficial bacteria (e.g. in the gut) that should not be killed since they are necessary for health.

Antibiotic research and treatment is a carefully planned intelligently designed process of breeding the human microbiome (the aggregate of bacteria that live in a human being). The purpose of breeding the microbiome is to eliminate the bacteria causing the disease but to preserve the beneficial bacteria (and to preserve the patient). Of necessity some of the bacteria must survive the treatment — the trick is to kill the pathological bacteria and leave only the beneficial bacteria alive. This cannot always be accomplished, and when it is not accomplished — that is, when some of the bacteria left alive are pathological and not beneficial — this is the development of antibiotic resistance. Antibiotic resistance in pathological bacteria is the undesirable consequence of the treatment of bacterial infections. It is not natural selection.

There are many strategies in place to minimize bacterial resistance to antibiotics, all of which are breeding the human microbiome — the process of treating a patient who has a bacterial infection. Antibiotic treatment of infections — both the desirable and undesirable consequences of the planned therapy — is the application of intelligent design principles to medical research and treatment.

Antibiotic treatment and the development of antibiotic resistance are artificial selection. Antibiotic treatment is not evolution, which is the consequence of unintelligent undirected unplanned natural selection. Evolution, understood in the Darwinian sense that Myers and other Darwinists intend, is precisely what antibiotic treatment is not. �

What’s remarkable here is that Myers and others like him don’t even understand what evolution is. They deny that intelligent design is evolution, yet they cite an obvious example of intelligent design (antibiotic treatment) as an example of evolution par excellence.

The treatment of infectious diseases with antibiotics is a superb example of intelligent design principles applied to medical research and human biology. Darwinian principles of evolution are not invoked by medical researchers because Darwinian principles contribute nothing to medical research, and medical researchers are relatively insulated from the career-threatening ideological pressure that permeates evolutionary biology.

Medical researchers are free to just do the science. The magnificent advances in medical care in modern times attest to the success of the application of design principles, not Darwinian fairy tales, to medical science.

Image: “Antibiotic resistance tests,” by Dr Graham Beards (Own work) [CC BY-SA 3.0], via Wikimedia Commons.

Michael Egnor

Senior Fellow, Center for Natural & Artificial Intelligence
Michael R. Egnor, MD, is a Professor of Neurosurgery and Pediatrics at State University of New York, Stony Brook, has served as the Director of Pediatric Neurosurgery, and award-winning brain surgeon. He was named one of New York’s best doctors by the New York Magazine in 2005. He received his medical education at Columbia University College of Physicians and Surgeons and completed his residency at Jackson Memorial Hospital. His research on hydrocephalus has been published in journals including Journal of Neurosurgery, Pediatrics, and Cerebrospinal Fluid Research. He is on the Scientific Advisory Board of the Hydrocephalus Association in the United States and has lectured extensively throughout the United States and Europe.

Share

Tags

Health & WellnessResearchscience